A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01

NCT06770933 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Retinopathy
NPDR - Non Proliferative Diabetic Retinopathy

Interventions

DRUG: VX-01
DRUG: Placebo

Sponsor

Vantage Biosciences Ltd

Collaborators

[object Object]